EUVIMEDEUVIMED entdecken
Crossref

Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy

Alexandra Paule, Soizic Masson, Johan Rose Dite Modestine, Norelyakin Kara, David Taieb, Emeline Colomba, Guillaume Crespel, Philippe D'Abadie, Karim Fard

Journal of Nuclear Medicine · 2026

DOI: 10.2967/jnumed.126.272126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Alexandra Paule und 8 weiteren Autor:innen. Beteiligte Einrichtung: Caribbean Institute of Nuclear Imaging, ICIN, CHU Martinique, Martinique, France. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Magnetic Resonance Imaging, Multimodal Imaging. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

18F-PSMA PET/CT and pelvic MRI are useful for assessing biochemical recurrence of prostate cancer after prostatectomy. We evaluated the role of 18F-PSMA PET/MRI in a 1-stop-shop protocol combining a single injection of 18F-PSMA, followed by pelvic PET/multiparametric MRI (mpMRI) and whole-body PET/CT acquisitions for the detection of recurrent disease.

Methods

We evaluated 106 consecutive patients referred to our institute for biochemical recurrence after prostatectomy using a 1-stop-shop protocol comprising whole-body 18F-PSMA PET/CT and pelvic 18F-PSMA PET/mpMRI. Each imaging modality was reviewed in a blinded manner by 2 independent, experienced readers. 18F-PSMA PET/MRI, with positivity on either MRI or PSMA PET, served as the reference standard.

Results

18F-PSMA PET/MRI detected more local recurrences (n = 52, 49.06%) compared with 18F-PSMA PET/CT (n = 42, 39.62%) and mpMRI (n = 46, 43.00%). Discordant cases accounted for 18 patients (17%): 10% were positive only on MRI and 7% only on PSMA PET. Compared with 18F-PSMA PET/MRI, both mpMRI and 18F-PSMA PET demonstrated similar performance, with sensitivities of 88.5% and 78.8% and specificities of 100% and 98.1%, respectively.

Conclusion

18F-PSMA PET/MRI outperformed PET/CT and mpMRI in the detection of local recurrences of prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatectomyMagnetic Resonance ImagingMultimodal ImagingNeoplasm Recurrence, LocalPositron-Emission TomographyEdetic AcidOligopeptidesHumansMaleAgedMiddle AgedPositron Emission Tomography Computed TomographyGlutaratesPhosphinic Acids

Stichwörter der Autor:innen

18F-PSMA PET/MRIbiochemical recurrenceprostate cancerprostatectomy

Substanzen

Edetic AcidOligopeptides(18)F-PSMA-11GlutaratesPhosphinic Acids

Autor:innen und Institutionen

  • Caribbean Institute of Nuclear Imaging, ICIN, CHU Martinique, Martinique, France.
  • Nuclear Imaging, CHU Timone, Marseille, France.
  • Urology Department, CHU Martinique, Martinique, France; and.
  • Oncology Department, CHU Martinique, France.
  • Caribbean Institute of Nuclear Imaging, ICIN, CHU Martinique, Martinique, France; kwfard@gmail.com karim.fard@chu-martinique.fr.
  • INSERM 1144, Université Paris Cité, Paris, France.

Zitieren

APA

Paule, A., Masson, S., Rose Dite Modestine, J., Kara, N., Taieb, D., Colomba, E., Crespel, G., D'Abadie, P., & Fard, K. (2026). Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272126

Vancouver

Paule A, Masson S, Rose Dite Modestine J, Kara N, Taieb D, Colomba E, et al. Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.126.272126

BibTeX
@article{Paule2026,
  author = {Paule, Alexandra and Masson, Soizic and Rose Dite Modestine, Johan and Kara, Norelyakin and Taieb, David and Colomba, Emeline and Crespel, Guillaume and D'Abadie, Philippe and Fard, Karim},
  title = {Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  doi = {10.2967/jnumed.126.272126}
}
Kostenlos starten →